COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,973 Articles (22,604 medRxiv, 8,369 bioRxiv)

Most recent first Previous |  Page 755: Articles 7541-7550  | Next

A SCID mouse model to evaluate the efficacy of antivirals against SARS-CoV-2 infection
Abdelnabi, R., Foo, C. S., Kaptein, S., Boudewijns, R., Vangeel, L., De Jonghe, S., Jochmans, D., Weynand, B., Neyts, J.
10.1101/2022.05.13.491916 — Posted: 2022-05-16
AI-based search for convergently expanding, advantageous mutations in SARS-CoV-2 by focusing on oligonucleotide frequencies
Ikemura, T., Iwasaki, Y., Wada, K., Wada, Y., Abe, T.
10.1101/2022.05.13.491763 — Posted: 2022-05-16
SARS-CoV-2 Omicron Variant Wave in India: Advent, Phylogeny and Evolution
Singh, U. B., Deb, S., Chaudhry, R., Bala, K., Rani, L., Gupta, R., Kumari, L., Ahmed, J., Gaurav, S., Perumalla, S., Nizam, M., Mishra, A., Stephenraj, J., Shukla, J., Bhardwaj, D., Nayer, J., Aggarwal, P., Kabra, M., Ahuja, V., Sinha, S., Guleria, R.
10.1101/2022.05.14.491911 — Posted: 2022-05-16
Assessment of oxidative stress markers in elderly patients with SARS-CoV-2 infection and potential prognostic implications. An observational study
Vazquez-Agra, N., Marques-Afonso, A.-T., Cruces-Sande, A., Novo-Veleiro, I., Pose-Reino, A., Mendez-Alvarez, E., Soto-Otero, R., hermida-Ameijeiras, a.
10.1101/2022.05.11.22274952 — Posted: 2022-05-16
Effects of social support on depression risk during the COVID-19 pandemic: What support types and for whom?
Choi, K. W., Lee, Y. H., Liu, Z., Fatori, D., Bauermeister, J. R., Luh, R. A., Clark, C. R., Brunoni, A. R., Bauermeister, S., Smoller, J. W.
10.1101/2022.05.15.22274976 — Posted: 2022-05-16
RT-RPA-Cas12a-based discrimination of SARS-CoV-2 variants of concern
Zhao, W., Tang, G., Zhang, Z., Tan, W., Fei, L., Sun, J., Li, Y., Zou, S., Yang, Y., Cai, K., Li, S., Wang, Z., Liu, J., Mao, G., Ma, Y., Zhao, G.-P., Tian, Z.-G.
10.1101/2022.05.11.22274884 — Posted: 2022-05-16
A Phase1 Results of a Non-Stabilized Spike-Encoding mRNA Vaccine in Adults
Gatechompol, S., Kittanamongkolchai, W., Ketloy, C., Prompetchara, E., Thitithanyanont, A., Jongkaewwattana, A., Buranapraditkun, S., Alameh, M.-G., Ubolyam, S., Sophonphan, J., Apornpong, T., Kerr, S., Kamarulzaman, A., Siwamogsatham, S., Kroon, E., Puthanakit, T., Patarakul, K., Palaga, T., Wijagkanalan, W., Weissman, D., Ruxrungtham, K.
10.1101/2022.05.12.22274989 — Posted: 2022-05-16
A Deterministic Agent-based Model with Antibody Dynamics Information in COVID-19 Epidemic Simulation
Xu, Z., Zhang, H.
10.1101/2022.05.11.22274979 — Posted: 2022-05-16
Human Mobility and Infection from Covid-19 in the Osaka Metropolitan Area
Haruka, K., Takizawa, A.
10.1101/2022.05.12.22274931 — Posted: 2022-05-16
Elevated expression of RGS2 may underlie reduced olfaction in COVID-19 patients
Avnat, E., Shapira, G., Gurwitz, D., Shomron, N.
10.1101/2022.05.12.22274991 — Posted: 2022-05-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).